Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Oral Muscle Relaxants for the Treatment of Chronic Pain Associated with Cerebral Palsy
1
x
$
30.00
Enfoque clínico: Conductas suicidas en adolescentes brasileños: análisis exploratorio de prevalencia y factores de riesgo
1
x
$
0.00
Psychopharmacology Bulletin VOL 49 No. 1, 2019 - Full Issue Stacked PDF
1
x
$
90.00
Thomas L. Schwartz, MD: Psychotropic Drug-Induced Weight Gain Alleviated with Orlistat: A Case Series
1
x
$
30.00
Clozapine Prolongs Cortical Silent Period in Patients with Treatment- Resistant Schizophrenia
1
x
$
30.00
Dextromethorphan in Cough Syrup: The Poor Man’s Psychosis
1
x
$
30.00
Consecuencias psicosociales de la depresión adolescente
1
x
$
0.00
Zonisamide for Bipolar Disorder, Mania or Mixed States by Deborah Dauphinais
1
x
$
30.00
Lori Davis, MD: Clinical and Pharmacoeconomic Evaluation of Switch to Olanzapine in Veterans with Schizophrenia or Schizoaffective Disorder
1
x
$
30.00
View Cart
Checkout
Home
bcpp
“Lori Davis, MD: Clinical and Pharmacoeconomic Evaluation of Switch to Olanzapine in Veterans with Schizophrenia or Schizoaffective Disorder” has been added to your cart.
View cart
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Lori Davis, MD: Clinical and Pharmacoeconomic Evaluation of Switch to Olanzapine in Veterans with Schizophrenia or Schizoaffective Disorder
$
30.00
Add to cart
Details
Vicki L. Ellingrod, PharmD, BCPP: Leptin and Leptin Receptor Gene Polymorphisms and Increases in Body Mass Index (BMI) from Olanzapine Treatment in Persons with Schizophrenia
$
30.00
Add to cart
Details
Page load link
Go to Top
